ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000244327.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.036733809	Resistant
ENSG00000244327.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.017181961	Sensitive